Table 1. AML Patients included in the study (n = 35).

Patient	Sex	% CCR2 BM	%CCR2 PB	Sample	Used for experiments
1	M	12	9	BM / PB	no
2	F	2.6	2	BM / PB	no
3	M	-	1.7	PB	no
4	M	63	45	BM / PB	no
5	F	1	3.5	BM/PB	no
6	F	2.6	1.2	BM/PB	no
7	F	1.3	4.8	BM/PB	no
8	F	27	22	BM/PB	no
9	M	6	6	BM/PB	yes
10	F	-	7.5	PB	no
11	M	-	19	PB	no
12	M	15	14	BM/PB	yes
13	M	16	6	BM/PB	yes
14	F	14	0	BM/PB	no
15	F	3	1.5	BM/PB	no
16	F	3	-	BM	yes
17	M	5.3	5.3	BM/PB	no
18	M	3.5	-	BM	no
19	M	8	6	PB/BM	no
20	M	0.1	-	BM	no
21	M	15	10	BM	yes
22	M	9	-	BM	no
23	F	3.3	-	BM	no
24	M	1	-	BM	yes
25	M	2.6	-	BM	no
26	M	8	7	BM/PB	yes
27	F	22	14	BM/PB	yes
28	M	15	-	BM	no
29	M	9	-	BM	yes
30	F	7.5	13.4	BM/PB	yes
31	F	11	-	BM	yes
32	M	55	53	BM/PB	yes
33	M	8.6	-	BM	yes
34	F	5	-	BM	yes
35	M	90	90	BM	yes

M, Male; F, Female; BM, bone marrow; PB, peripheral blood.